SSII

SS Innovations International Inc. Common Stock
SSII
Market cap $2.03B

10.48 USD

Updated Apr 28, 1:45 PM EDT

1 day

0.00%

5 days

0.00%

1 month

0.00%

3 months

0.00%

6 months

0.00%

Year to date

0.00%

1 year

0.00%

5 years

0.00%

10 years

0.00%

About: SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.

Employees: 378

Healthcare Medical Devices

–

Funds holding %

–

Analysts bullish %

Fund manager confidence

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SSII.

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about SSII published over the past 30 days

SS Innovations to Uplist to Nasdaq

Listened: Fort Lauderdale, FL, April 24, 2025 – PRISM MediaWire – SS Innovations International, Inc.

SS Innovations to Uplist to Nasdaq

SS Innovations to Uplist to Nasdaq

FORT LAUDERDALE, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”).

SS Innovations to Uplist to Nasdaq

SS Innovations Achieves Significant Milestones in 2024

FORT LAUDERDALE, FL, March 31, 2025 – PRISM MediaWire – SS Innovations International, Inc.

SS Innovations Achieves Significant Milestones in 2024

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

Fort Lauderdale, Fla. March 28, 2025 – PRISM MediaWire – SS Innovations International, Inc.

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine.

SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India's first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures.

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

Fort Lauderdale, FL, March 27, 2025 – PRISM MediaWire – SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative robotic surgical technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it successfully performed India's first North-to-South robotic cardiac telesurgery.

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery at the Company's Second Global Multi-Specialty Robotic Surgery Conference (SMRSC), which was held in Gurugram, Delhi National Capital Region (NCR), India, from March 7 - 9, 2025.

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

Fort Lauderdale, FL, March 13, 2025 – PRISM MediaWire – SS Innovations International, Inc.

SS Innovations Unveils India's First Mobile Tele-Surgical Unit at SMRSC 2025

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

Fort Lauderdale, Fla., March 7, 2025 – PRISM MediaWire – SS Innovations International, Inc.

SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025

See News Rankings

Charts implemented using Lightweight Charts™